Correction to: Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases (International Journal of Clinical Oncology, (2022), 27, 2, (301-309), 10.1007/s10147-021-02082-9)

Masanori Ono; Kimikazu Matsumoto; Narikazu Boku; Nobuharu Fujii; Yumi Tsuchida; Tatsuro Furui; Miyuki Harada; Yoshinobu Kanda; Akira Kawai; Mitsuru Miyachi; Atsuko Murashima; Robert Nakayama; Hiroyuki Nishiyama; Chikako Shimizu; Kazuhiko Sugiyama; Yasushi Takai; Keishi Fujio; Ken Ichirou Morishige; Yutaka Osuga; Nao Suzuki

doi:10.1007/s10147-022-02138-4

Correction to: Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases (International Journal of Clinical Oncology, (2022), 27, 2, (301-309), 10.1007/s10147-021-02082-9)

Masanori Ono, Kimikazu Matsumoto, Narikazu Boku, Nobuharu Fujii, Yumi Tsuchida, Tatsuro Furui, Miyuki Harada, Yoshinobu Kanda, Akira Kawai, Mitsuru Miyachi, Atsuko Murashima, Robert Nakayama, Hiroyuki Nishiyama, Chikako Shimizu, Kazuhiko Sugiyama, Yasushi Takai, Keishi Fujio, Ken Ichirou Morishige, Yutaka Osuga, Nao Suzuki

University Hospital

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The article, Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases written by Masanori Ono, Kimikazu Matsumoto, Narikazu Boku, Nobuharu Fujii, Yumi Tsuchida, Tatsuro Furui, Miyuki Harada, Yoshinobu Kanda, Akira Kawai, Mitsuru Miyachi, Atsuko Murashima, Robert Nakayama, Hiroyuki Nishiyama, Chikako Shimizu, Kazuhiko Sugiyama, Yasushi Takai, Keishi Fujio, Ken‑Ichirou Morishige, Yutaka Osuga, and Nao Suzuki was originally published Online First without Open Access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on February 16, 2022 to

Original language	English
Pages (from-to)	825-826
Number of pages	2
Journal	International Journal of Clinical Oncology
Volume	27
Issue number	4
DOIs	https://doi.org/10.1007/s10147-022-02138-4
Publication status	Published - Apr 2022

ASJC Scopus subject areas

Surgery
Hematology
Oncology

Access to Document

10.1007/s10147-022-02138-4

Fingerprint

Dive into the research topics of 'Correction to: Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases (International Journal of Clinical Oncology, (2022), 27, 2, (301-309), 10.1007/s10147-021-02082-9)'. Together they form a unique fingerprint.

Cite this

Ono, M., Matsumoto, K., Boku, N., Fujii, N., Tsuchida, Y., Furui, T., Harada, M., Kanda, Y., Kawai, A., Miyachi, M., Murashima, A., Nakayama, R., Nishiyama, H., Shimizu, C., Sugiyama, K., Takai, Y., Fujio, K., Morishige, K. I., Osuga, Y., & Suzuki, N. (2022). Correction to: Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases (International Journal of Clinical Oncology, (2022), 27, 2, (301-309), 10.1007/s10147-021-02082-9). International Journal of Clinical Oncology, 27(4), 825-826. https://doi.org/10.1007/s10147-022-02138-4

Correction to: Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases (International Journal of Clinical Oncology, (2022), 27, 2, (301-309), 10.1007/s10147-021-02082-9). / Ono, Masanori; Matsumoto, Kimikazu; Boku, Narikazu et al.
In: International Journal of Clinical Oncology, Vol. 27, No. 4, 04.2022, p. 825-826.

Research output: Contribution to journal › Comment/debate › peer-review

Ono, M, Matsumoto, K, Boku, N, Fujii, N, Tsuchida, Y, Furui, T, Harada, M, Kanda, Y, Kawai, A, Miyachi, M, Murashima, A, Nakayama, R, Nishiyama, H, Shimizu, C, Sugiyama, K, Takai, Y, Fujio, K, Morishige, KI, Osuga, Y & Suzuki, N 2022, 'Correction to: Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases (International Journal of Clinical Oncology, (2022), 27, 2, (301-309), 10.1007/s10147-021-02082-9)', International Journal of Clinical Oncology, vol. 27, no. 4, pp. 825-826. https://doi.org/10.1007/s10147-022-02138-4

Ono M, Matsumoto K, Boku N, Fujii N, Tsuchida Y, Furui T et al. Correction to: Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases (International Journal of Clinical Oncology, (2022), 27, 2, (301-309), 10.1007/s10147-021-02082-9). International Journal of Clinical Oncology. 2022 Apr;27(4):825-826. doi: 10.1007/s10147-022-02138-4

Ono, Masanori ; Matsumoto, Kimikazu ; Boku, Narikazu et al. / Correction to : Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases (International Journal of Clinical Oncology, (2022), 27, 2, (301-309), 10.1007/s10147-021-02082-9). In: International Journal of Clinical Oncology. 2022 ; Vol. 27, No. 4. pp. 825-826.

@article{c30e986a179d48b88910e566bee6bbc1,

title = "Correction to: Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases (International Journal of Clinical Oncology, (2022), 27, 2, (301-309), 10.1007/s10147-021-02082-9)",

abstract = "The article, Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases written by Masanori Ono, Kimikazu Matsumoto, Narikazu Boku, Nobuharu Fujii, Yumi Tsuchida, Tatsuro Furui, Miyuki Harada, Yoshinobu Kanda, Akira Kawai, Mitsuru Miyachi, Atsuko Murashima, Robert Nakayama, Hiroyuki Nishiyama, Chikako Shimizu, Kazuhiko Sugiyama, Yasushi Takai, Keishi Fujio, Ken‑Ichirou Morishige, Yutaka Osuga, and Nao Suzuki was originally published Online First without Open Access. With the author(s){\textquoteright} decision to opt for Open Choice the copyright of the article changed on February 16, 2022 to",

author = "Masanori Ono and Kimikazu Matsumoto and Narikazu Boku and Nobuharu Fujii and Yumi Tsuchida and Tatsuro Furui and Miyuki Harada and Yoshinobu Kanda and Akira Kawai and Mitsuru Miyachi and Atsuko Murashima and Robert Nakayama and Hiroyuki Nishiyama and Chikako Shimizu and Kazuhiko Sugiyama and Yasushi Takai and Keishi Fujio and Morishige, {Ken Ichirou} and Yutaka Osuga and Nao Suzuki",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",

year = "2022",

month = apr,

doi = "10.1007/s10147-022-02138-4",

language = "English",

volume = "27",

pages = "825--826",

journal = "International Journal of Clinical Oncology",

issn = "1341-9625",

publisher = "Springer Japan",

number = "4",

}

TY - JOUR

T1 - Correction to

T2 - Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases (International Journal of Clinical Oncology, (2022), 27, 2, (301-309), 10.1007/s10147-021-02082-9)

AU - Ono, Masanori

AU - Matsumoto, Kimikazu

AU - Boku, Narikazu

AU - Fujii, Nobuharu

AU - Tsuchida, Yumi

AU - Furui, Tatsuro

AU - Harada, Miyuki

AU - Kanda, Yoshinobu

AU - Kawai, Akira

AU - Miyachi, Mitsuru

AU - Murashima, Atsuko

AU - Nakayama, Robert

AU - Nishiyama, Hiroyuki

AU - Shimizu, Chikako

AU - Sugiyama, Kazuhiko

AU - Takai, Yasushi

AU - Fujio, Keishi

AU - Morishige, Ken Ichirou

AU - Osuga, Yutaka

AU - Suzuki, Nao

PY - 2022/4

Y1 - 2022/4

N2 - The article, Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases written by Masanori Ono, Kimikazu Matsumoto, Narikazu Boku, Nobuharu Fujii, Yumi Tsuchida, Tatsuro Furui, Miyuki Harada, Yoshinobu Kanda, Akira Kawai, Mitsuru Miyachi, Atsuko Murashima, Robert Nakayama, Hiroyuki Nishiyama, Chikako Shimizu, Kazuhiko Sugiyama, Yasushi Takai, Keishi Fujio, Ken‑Ichirou Morishige, Yutaka Osuga, and Nao Suzuki was originally published Online First without Open Access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on February 16, 2022 to

AB - The article, Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases written by Masanori Ono, Kimikazu Matsumoto, Narikazu Boku, Nobuharu Fujii, Yumi Tsuchida, Tatsuro Furui, Miyuki Harada, Yoshinobu Kanda, Akira Kawai, Mitsuru Miyachi, Atsuko Murashima, Robert Nakayama, Hiroyuki Nishiyama, Chikako Shimizu, Kazuhiko Sugiyama, Yasushi Takai, Keishi Fujio, Ken‑Ichirou Morishige, Yutaka Osuga, and Nao Suzuki was originally published Online First without Open Access. With the author(s)’ decision to opt for Open Choice the copyright of the article changed on February 16, 2022 to

UR - http://www.scopus.com/inward/record.url?scp=85124950437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85124950437&partnerID=8YFLogxK

U2 - 10.1007/s10147-022-02138-4

DO - 10.1007/s10147-022-02138-4

M3 - Comment/debate

C2 - 35188618

AN - SCOPUS:85124950437

SN - 1341-9625

VL - 27

SP - 825

EP - 826

JO - International Journal of Clinical Oncology

JF - International Journal of Clinical Oncology

IS - 4

ER -

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this